Wan-Ting Huang Selected Research

Ligands

11/2019

Positive Programmed Cell Death-Ligand 1 Expression Predicts Poor Treatment Outcomes in Esophageal Squamous Cell Carcinoma Patients Receiving Neoadjuvant Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wan-Ting Huang Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 04/2002
12	Esophageal Squamous Cell Carcinoma 11/2019 - 08/2012
9	Human Influenza (Influenza) 06/2023 - 10/2010
8	Infections 03/2024 - 08/2007
6	Hemorrhage 11/2023 - 02/2012
4	Lymphoma (Lymphomas) 12/2023 - 08/2009
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 02/2009
3	Sepsis (Septicemia) 03/2024 - 08/2007
3	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 06/2022
3	COVID-19 06/2023 - 10/2020
3	Narcolepsy 01/2020 - 01/2018
3	Whooping Cough (Pertussis) 01/2017 - 08/2010
3	Tetanus 01/2017 - 08/2010
3	Diphtheria 01/2017 - 08/2010
2	Inflammation (Inflammations) 03/2024 - 03/2007
2	Lymphadenopathy 12/2023 - 03/2016
2	Ischemic Stroke 11/2023 - 01/2020
2	Pneumonia (Pneumonitis) 06/2023 - 01/2020
2	Chronic Renal Insufficiency 12/2022 - 11/2021
2	Colitis 08/2022 - 12/2011
2	Chickenpox 10/2021 - 01/2020
2	Liver Diseases (Liver Disease) 01/2021 - 11/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 03/2012
2	Periodontal Diseases (Periodontal Disease) 01/2019 - 01/2018
2	Squamous Cell Carcinoma of Head and Neck 07/2017 - 01/2016
2	Pathologic Complete Response 01/2017 - 12/2012
2	Carcinogenesis 01/2017 - 06/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2016 - 06/2014
2	Wounds and Injuries (Trauma) 12/2015 - 09/2011
2	Epstein-Barr Virus Infections 01/2013 - 02/2009
2	Guillain-Barre Syndrome 01/2013 - 03/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2012 - 03/2007
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 03/2024
1	Dementia (Dementias) 02/2024
1	Normal Pressure Hydrocephalus 02/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2024
1	Chronic Disease (Chronic Diseases) 01/2024
1	Rhinosinusitis 12/2023
1	Allergic Rhinitis 12/2023
1	Syphilis 12/2023
1	Hepatitis B 12/2023
1	Stroke (Strokes) 11/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023
1	Breast Neoplasms (Breast Cancer) 05/2023
1	Sensorineural Hearing Loss 12/2022

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 12/2022 - 03/2010
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2019
4	CytokinesIBA 03/2024 - 12/2009
4	TOR Serine-Threonine KinasesIBA 01/2017 - 12/2012
3	AutoantibodiesIBA 12/2023 - 03/2016
3	Warfarin (Coumadin)FDA LinkGeneric 11/2023 - 12/2015
3	methyl 4-thio-alpha-maltosideIBA 06/2022 - 02/2019
3	Bromodeoxyuridine (BrdU)IBA 01/2019 - 01/2017
3	Antiviral Agents (Antivirals)IBA 01/2018 - 01/2012
3	Pertussis VaccineIBA 01/2017 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 03/2015 - 02/2009
2	AntibodiesIBA 01/2024 - 04/2020
2	InterferonsIBA 12/2023 - 01/2023
2	Vitamin K FDA Link 11/2023 - 11/2017
2	Interferon-gamma (Interferon, gamma)IBA 01/2023 - 03/2016
2	AcidsIBA 07/2022 - 09/2015
2	EnzymesIBA 07/2022 - 12/2015
2	SolutionsIBA 06/2022 - 01/2022
2	Prothrombin (Factor II)IBA 01/2021 - 11/2017
2	insulin receptor-related receptor (IRR)IBA 11/2020 - 01/2020
2	Inosine Triphosphate (ITP)IBA 01/2020 - 03/2012
2	Immunoglobulin M (IgM)IBA 08/2019 - 08/2006
2	AntioxidantsIBA 01/2019 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2013
2	Insulin Receptor Substrate ProteinsIBA 10/2018 - 01/2015
2	Everolimus FDA Link 01/2017 - 10/2016
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2017 - 01/2013
2	Immunoglobulin G (IgG)IBA 10/2016 - 03/2016
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 01/2016 - 03/2015
2	Protein Kinases (Protein Kinase)IBA 01/2016 - 03/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2011 - 08/2007
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 12/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	Histamine Antagonists (Antihistamines)IBA 12/2023
1	AnticoagulantsIBA 11/2023
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2023
1	N(4)-oleylcytosine arabinosideIBA 11/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023

Therapy/Procedure

16	Therapeutics 11/2023 - 10/2009
4	Chemoradiotherapy 01/2018 - 12/2012
4	Drug Therapy (Chemotherapy) 12/2012 - 11/2005
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024 - 04/2020
3	Esophagectomy 12/2015 - 08/2012
2	Precision Medicine 05/2023 - 01/2022
2	Immunotherapy 01/2022 - 04/2020
2	Long-Term Care 10/2020 - 01/2018
2	Radiotherapy 09/2015 - 01/2011
1	Cerebrospinal Fluid Shunts 02/2024
1	Lymph Node Excision (Lymph Node Dissection) 12/2023
1	Intravenous Infusions 12/2023
1	Renal Dialysis (Hemodialysis) 12/2023
1	Personal Protective Equipment 06/2023